As of April 29, 2025, Ensysce Biosciences (ENSC) has a market cap of $5.016 million USD. According to our data, Ensysce Biosciences is ranked No.9011 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $5.02 M |
-52.77%
|
Dec 31, 2024 | $10.62 M |
-48.81%
|
Dec 29, 2023 | $20.75 M |
-88.22%
|
Dec 30, 2022 | $0.18 B |
-99.20%
|
Dec 31, 2021 | $22.08 B |
-62.20%
|
Dec 31, 2020 | $58.42 B |
19.34%
|
Dec 31, 2019 | $48.95 B |
6.11%
|
Dec 31, 2018 | $46.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Trevena
TRVN
|
$1.05 M |
0.000 M
|
![]() USA
|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() Collegium Pharmaceutical
COLL
|
$0.89 B |
0.000 M
|
![]() USA
|
![]() Pacira Biosciences
PCRX
|
$1.25 B |
0.000 M
|
![]() USA
|
![]() Assertio Therapeutics
ASRT
|
$63.15 M |
0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.14 B |
-0.000 M
|
![]() USA
|
![]() Heron Therapeutics
HRTX
|
$0.36 B |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.74 B |
0.000 M
|
![]() Ireland
|
Market Cap | = | ENSC Stock Price | * | ENSC Shares Outstanding |
= | $3.05 | * | 1.64 M | |
= | $5.02 M |